PAVmed Inc.

SecurityPAVM / PAVmed Inc.
InstitutionMorgan Stanley
Latest Disclosed Ownership165 shares
Latest Disclosed Value $ 1,675
Morgan Stanley reports 99.71% decrease in ownership of PAVM / PAVmed Inc.

On May 15, 2026 - Morgan Stanley filed a 13F-HR form disclosing ownership of 165 shares of PAVmed Inc. (US:PAVM) valued at $1,675 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 4,826 shares of PAVmed Inc.. This represents a change in shares of -99.71% during the quarter. The current value of the position is $904 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F PAVMED COM 70387R502 165 -56,074 -99.71 2 -93.75 0.0000
2023-11-15 2023-09-30 13F PAVMED COM 70387R106 56,239 -24,036 -29.94 17 -50.00 0.0000
2023-08-14 2023-06-30 13F PAVMED COM 70387R106 80,275 -20,114 -20.04 33 -13.51 0.0000
2023-05-15 2023-03-31 13F PAVMED COM 70387R106 100,389 -32,992 -24.74 37 -42.19 0.0000
2023-02-14 2022-12-31 13F PAVMED COM 70387R106 133,381 -45,120 -25.28 64 -58.44 0.0000
2022-11-14 2022-09-30 13F PAVMED COM 70387R106 178,501 -66,442 -27.13 154 -32.75 0.0000
2022-10-27 2022-06-30 13F/A-1 PAVMED COM 70387R106 244,943 -206,491 -45.74 229 -61.58 0.0000
2022-08-15 2022-06-30 13F PAVMED COM 70387R106 244,943 229
2022-10-27 2022-03-31 13F/A-1 PAVMED COM 70387R106 451,434 -668,120 -59.68 596 -78.37 0.0001
2022-05-13 2022-03-31 13F PAVMED COM 70387R106 451,434 596
2022-02-14 2021-12-31 13F PAVMED COM 70387R106 1,119,554 -19,722 -1.73 2,755 -71.68 0.0003
2021-11-15 2021-09-30 13F PAVMED COM 70387R106 1,139,276 372,980 48.67 9,729 98.35 0.0013
2021-08-23 2021-06-30 13F/A-1 PAVMED COM 70387R106 766,296 166,293 27.72 4,905 84.12 0.0006
2021-08-16 2021-06-30 13F PAVMED COM 70387R106 766,296 766,096 4,905 0.0006
2021-05-17 2021-03-31 13F PAVMED COM 70387R106 600,003 195,606 48.37 2,664 210.85 0.0004
2021-02-16 2020-12-31 13F PAVMED COM 70387R106 404,397 291,193 257.23 857 324.26 0.0001
2020-11-13 2020-09-30 13F PAVMED COM 70387R106 113,204 -716 -0.63 202 -15.83 0.0000
2020-08-14 2020-06-30 13F PAVMED COM 70387R106 113,920 55,502 95.01 240 106.90 0.0001
2020-05-26 2020-03-31 13F/A-1 PAVMED COM 70387R106 58,418 58,418 -48.72 116 -51.67 0.0000
2020-05-15 2020-03-31 13F PAVMED COM 70387R106 58,418 58,418 116 8.9112
2019-02-14 2018-12-31 13F PAVMED COM 70387R106 0 -8,962 -100.00 0 -100.00
2019-04-23 2018-09-30 13F/A-2 PAVMED COM 70387R106 8,962 -1,990 -18.17 12 20.00 0.0000
2018-11-20 2018-09-30 13F/A-1 PAVMED COM 70387R106 8,962 0 12 0.0000
2018-11-14 2018-09-30 13F PAVMED COM 70387R106 8,962 8,893 12
2019-04-23 2018-06-30 13F/A-1 PAVMED COM 70387R106 10,952 0 0.00 10 -44.44 0.0000
2018-08-14 2018-06-30 13F PAVMED COM 70387R106 10,952 0 10
2019-04-23 2018-03-31 13F/A-1 PAVMED COM 70387R106 10,952 0 0.00 18 -28.00 0.0000
2018-05-14 2018-03-31 13F PAVMED COM 70387R106 10,952 0 18
2019-04-23 2017-12-31 13F/A-1 PAVMED COM 70387R106 10,952 10,952 25 0.0000
2018-02-14 2017-12-31 13F PAVMED COM 70387R106 10,952 25 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.